Group 3 Pulmonary Hypertension: From Bench to Bedside



Invalid Access Key!

Invalid Access Key!


Uploaded Image

Comments

Post a Comment

Popular posts from this blog

4 Symptoms of Stress You Should Never Ignore - AARP

Image
Vadym Pastukh/Getty Images Wins and medals aren't the only things grabbing attention at this year's Olympic games in Tokyo: Mental health awareness is also in the spotlight, after U.S. star gymnast Simone Biles' decision to withdraw from some events in order to focus on her emotional well-being.  Olympians or not, we're all susceptible to stress, whether from job or family pressures or obligations like caregiving. Here are the physical and mental signs that experts say could signal trouble.   1. Insomnia and difficulty sleeping  Can't fall or stay asleep? Insomnia is a class...
Read more

What is lung scraping for COPD, and who may need it? - Medical News Today

Image
Lung scraping, or thoracentesis, involves the removal of fluid or air from the space between the chest wall and the lungs. In some cases, doctors may perform the procedure on people who have chronic obstructive pulmonary disease (COPD). It is not a standard treatment for COPD, but it may be necessary if a person has pleural effusion or empyema. This article looks at COPD and lung scraping in more detail. It explains who may need the procedure and discusses the risks, preparation, and aftercare. It also outlines other procedures for COPD. Lung scraping involves removing air or excess fluid from the pleural space. The pleural space is the area between the lungs and the chest wall. The medical term for lung scraping is thoracentesis. Doctors perform the procedure for therapeutic reasons or diagnostic purposes. Therapeutic thoracentesis helps decrease the shortness of breath and pain that result from the pressure of the fluid on the lungs. It typically involves the removal of a large volu...
Read more

FDA Names SoniVie's TIVUS System a Breakthrough Device for PAH - Pulmonary Hypertension News

Image
FDA Names SoniVie's TIVUS System a Breakthrough Device for PAH - Pulmonary Hypertension News FDA Names SoniVie's TIVUS System a Breakthrough Device for PAH - Pulmonary Hypertension News Posted: 11 Sep 2019 05:00 AM PDT The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to SoniVie's Therapeutic Intra-Vascular Ultrasound (TIVUS) System for the treatment of people with pulmonary arterial hypertension (PAH). Similar to breakthrough therapy , the designation of breakthrough device is given to medical equipment that provides significant advantages over currently available options. It is intended to accelerate the development, review, and approval of devices that have been designed to treat irreversibly debilitating or life-threatening conditions. "There are no approved medical device treatment options for PAH, only medications. The TIVUS Sy...
Read more